Molecular Diagnostics
AI Tool ‘Sees’ Cancer Gene Signatures in Biopsy Images
An AI-powered computational tool that can predict the activity of thousands of genes within tumor cells has demonstrated the ability to predict genetic variations in breast cancers and patient outcomes, all based on routine biopsy images. More...18 Nov 2024
.jpg "Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)")
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Rapid Sepsis Test
SeptiCyte RAPID
Clinical Informatics Platform
CLARION™
In Other News
Novel Method Analyzes Genetic Variations in Families with High Incidence of Breast Cancer
cfDNA Testing Reduces Pregnancy Risks
Non-Invasive Biosensor Facilitates Early Kidney Disease Detection
New High-Sensitivity Cardiac Troponin Test Quickly Rules Out Heart Attack
Gene Technology Outperforms Standard Newborn Screening Tests in Pioneering Study
Maternal Blood Test Identifies Congenital Heart Diseases in Fetus
Enhanced Ultra-Sensitive Protocol Detects Parkinson’s Disease Proteins in Extracellular Vesicles in Blood
New RNA Molecules Can Help Predict Bowel Cancer Recurrence
Respiratory Panel to Help Clinicians Make Precise Treatment Decisions in Outpatient Settings
Integrating Cardiovascular Risk Biomarkers Aids in Detection of ‘Inflammaging’
Genetic Signature in Newborns Predicts Neonatal Sepsis Before Symptoms Appear
Integrating Multiple Protein Markers Predicts Health Outcomes in Chronic Kidney Disease Patients
Rapid Finger Prick Blood Test to Detect Active Syphilis at Point of Care
Urine Tests Could Reveal Early Signs of Cancer and Other Diseases
AI-Powered Smart PCR System to Revolutionize Clinical Diagnostics
Simple Blood Test Identifies Women in Labor at Risk for Preeclampsia
Sepsis Test Demonstrates Clinical Utility in Critically Ill Heterogeneous Patient Populations
Point-Of-Care Paper-Based Test Could Diagnose Cancer at Bedside
Multi-Cancer Early Detection Test Measures Host Response to Tumor Development
MicroRNA-Based Test Identifies 12 Cancers Simultaneously Across Any Stage
New Blood Test Platform Simultaneously Measures Over 100 Biomarkers of Alzheimer's Disease
Epigenetic Test Could Determine Efficacy of New Immunotherapy Treatments Against Multiple Myeloma
First-Ever Blood Test Diagnoses Maternal Autoantibody Related Autism
Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.
